Nifty
Sensex
:
:
13258.55
45079.55
124.65 (0.95%)
446.90 (1.00%)

Pharmaceuticals & Drugs

Rating :
70/99  (View)

BSE: 524212 | NSE: WANBURY

36.15
-0.30 (-0.82%)
04-Dec-2020 | 3:58PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  36.40
  •  37.80
  •  36.00
  •  36.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  26330
  •  9.52
  •  44.75
  •  16.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 91.18
  • 1.41
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 238.12
  • N/A
  • -0.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.09%
  • 11.56%
  • 27.40%
  • FII
  • DII
  • Others
  • 0%
  • 1.34%
  • 7.61%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.53
  • -2.79
  • -0.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.43
  • -
  • -20.46

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.48
  • -0.48
  • -0.48

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.95
  • 21.10
  • 23.04

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
95
109
-13%
67
94
-29%
67
102
-34%
0
0
0
Expenses
86
94
-9%
70
86
-18%
75
94
-21%
0
0
0
EBITDA
9
15
-40%
-3
9
-
-8
7
-
0
0
0
EBIDTM
9%
14%
-4%
9%
-12%
7%
0%
0%
Other Income
0
0
-62%
0
0
53%
1
7
-91%
0
0
0
Interest
5
8
-36%
6
7
-15%
10
22
-53%
0
0
0
Depreciation
2
2
-2%
2
2
-4%
2
2
-2%
0
0
0
PBT
2
5
-66%
-11
-1
-
63
-10
-
0
0
0
Tax
0
0
-
0
0
-
0
0
-
0
0
0
PAT
2
5
-68%
-11
-1
-
62
-10
-
0
0
0
PATM
2%
5%
-17%
-1%
93%
-10%
0%
0%
EPS
0.64
2.01
-68%
-4.46
-0.33
-
24.95
-3.96
-
0.00
0.00
0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Sep 14
Mar 13
Mar 12
Mar 11
Net Sales
-
367
391
371
434
423
250
662
459
386
387
Net Sales Growth
-
-6%
5%
-14%
2%
69%
-62%
44%
19%
0%
 
Cost Of Goods Sold
-
176
196
174
197
182
119
304
250
191
187
Gross Profit
-
192
195
197
237
241
131
358
209
195
201
GP Margin
-
52%
50%
53%
55%
57%
52%
54%
46%
51%
52%
Total Expenditure
-
389
378
439
415
391
228
638
491
389
429
Power & Fuel Cost
-
15
14
15
19
19
10
28
18
15
16
% Of Sales
-
4%
4%
4%
4%
4%
4%
4%
4%
4%
4%
Employee Cost
-
67
76
87
88
85
40
112
81
81
91
% Of Sales
-
18%
19%
23%
20%
20%
16%
17%
18%
21%
24%
Manufacturing Exp.
-
14
8
10
15
12
3
15
8
6
5
% Of Sales
-
4%
2%
3%
3%
3%
1%
2%
2%
2%
1%
General & Admin Exp.
-
29
30
30
34
30
25
47
36
34
36
% Of Sales
-
8%
8%
8%
8%
7%
10%
7%
8%
9%
9%
Selling & Distn. Exp.
-
20
27
29
42
34
15
62
37
33
48
% Of Sales
-
5%
7%
8%
10%
8%
6%
9%
8%
9%
12%
Miscellaneous Exp.
-
69
26
93
20
28
16
69
61
29
48
% Of Sales
-
19%
7%
25%
5%
7%
6%
10%
13%
7%
12%
EBITDA
-
-22
13
-68
19
32
21
24
-32
-3
-42
EBITDA Margin
-
-6%
3%
-18%
4%
8%
9%
4%
-7%
-1%
-11%
Other Income
-
46
12
77
90
1
6
11
5
13
14
Interest
-
33
40
31
36
32
19
48
37
40
47
Depreciation
-
10
10
10
10
9
5
23
23
17
16
PBT
-
-18
-25
-32
62
-7
4
-36
-87
-47
-91
Tax
-
0
0
0
0
0
1
3
0
0
-7
Tax Rate
-
0%
1%
1%
1%
0%
28%
-2%
0%
0%
8%
PAT
-
64
-25
-32
62
-7
3
-128
-87
-39
-84
PAT before Minority Interest
-
64
-25
-32
62
-7
3
-128
-87
-39
-84
Minority Interest
-
0
0
0
0
0
0
0
0
0
0
PAT Margin
-
18%
-6%
-9%
14%
-2%
1%
-19%
-19%
-10%
-22%
PAT Growth
-
359%
22%
-152%
967%
-323%
103%
-46%
-124%
54%
 
EPS
-
25.78
-9.94
-12.80
24.80
-2.86
1.28
-51.08
-34.89
-15.56
-33.52

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Sep 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
-143
-209
-185
-153
-189
-194
-192
-48
44
78
Share Capital
25
24
24
23
20
20
20
17
17
15
Total Reserves
-169
-233
-209
-176
-221
-214
-212
-65
27
64
Non-Current Liabilities
108
130
106
160
251
298
312
347
272
191
Secured Loans
100
123
99
154
231
270
279
310
261
105
Unsecured Loans
0
0
0
0
0
0
0
0
0
60
Long Term Provisions
12
11
10
10
9
7
7
7
6
4
Current Liabilities
311
362
348
402
299
265
259
447
466
466
Trade Payables
122
112
83
140
86
99
94
78
83
79
Other Current Liabilities
161
161
179
194
119
85
89
284
289
192
Short Term Borrowings
25
85
83
63
91
78
74
74
82
183
Short Term Provisions
4
3
4
4
3
2
2
11
11
12
Total Liabilities
275
283
269
409
388
396
406
773
809
761
Net Block
164
172
178
186
180
164
174
423
439
439
Gross Block
203
202
199
197
326
306
310
593
581
554
Accumulated Depreciation
39
30
20
10
145
142
136
170
142
115
Non Current Assets
182
185
192
217
224
215
219
583
584
570
Capital Work in Progress
14
9
10
10
14
19
13
25
17
14
Non Current Investment
0
0
0
0
0
0
0
1
1
1
Long Term Loans & Adv.
4
3
3
20
29
31
32
134
127
117
Other Non Current Assets
0
0
0
0
0
1
1
0
0
0
Current Assets
94
98
78
192
164
181
187
190
225
191
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
12
19
13
34
35
34
35
43
59
49
Sundry Debtors
51
44
29
85
75
99
103
84
114
97
Cash & Bank
17
5
6
9
7
12
7
17
16
9
Other Current Assets
14
26
23
26
47
37
42
46
36
36
Short Term Loans & Adv.
4
3
6
37
29
17
22
36
22
20
Net Current Assets
-217
-263
-271
-210
-135
-84
-73
-257
-241
-275
Total Assets
275
283
269
409
388
396
406
773
809
761

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Sep 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
44
30
32
43
43
40
68
87
9
137
PBT
65
-25
-32
62
-7
4
-125
-87
-39
-91
Adjustment
-41
43
40
-37
48
23
191
94
60
75
Changes in Working Capital
21
12
26
18
2
13
2
81
-12
157
Cash after chg. in Working capital
44
30
33
43
43
40
68
87
9
141
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
0
0
-1
0
0
0
0
0
0
-4
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
64
-3
-1
-13
-20
-5
-6
-21
-32
-10
Net Fixed Assets
-6
-2
-2
134
-16
-1
-7
-15
-8
-3
Net Investments
0
0
0
0
0
0
106
0
-1
-3
Others
70
-1
1
-147
-4
-4
-105
-5
-23
-4
Cash from Financing Activity
-108
-27
-33
-27
-28
-30
-71
-64
24
-129
Net Cash Inflow / Outflow
0
0
-2
3
-5
5
-9
3
2
-2
Opening Cash & Equivalents
3
3
5
2
6
1
10
7
5
7
Closing Cash & Equivalent
3
3
3
5
2
6
1
10
7
5

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Sep 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
-57
-88
-78
-66
-112
-109
-109
-53
-3
18
ROA
23%
-9%
-9%
16%
-2%
1%
-22%
-11%
-5%
-11%
ROE
0%
0%
0%
0%
0%
0%
0%
0%
-366%
-122%
ROCE
444%
50%
-2%
70%
15%
14%
-31%
-13%
0%
-8%
Fixed Asset Turnover
1.83
2.08
1.89
1.70
1.37
0.83
1.50
0.80
0.69
0.72
Receivable days
47
32
56
66
73
145
51
77
98
112
Inventory Days
16
14
23
28
29
49
21
40
50
47
Payable days
144
106
126
111
100
183
57
72
84
81
Cash Conversion Cycle
-82
-59
-47
-17
2
11
14
45
65
79
Total Debt/Equity
-1.14
-1.11
-1.19
-1.76
-1.67
-1.74
-1.79
-4.47
-88.47
15.95
Interest Cover
3
0
0
3
1
1
-2
-1
0
-1

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.